Unitree's $904 million IPO opens humanoid robot listing wave

Unitree's 8,000-times oversubscribed Shanghai debut marks the first of a wave of humanoid robot IPOs hitting Chinese markets.

Unitree's 6.1 billion yuan ($904 million) Shanghai IPO, oversubscribed more than 8,000 times by retail investors, makes it the first mainland-listed humanoid robot maker and opens the door for a wave of robotics listings.

"Such exuberance for a firm valued at some 100 times earnings was once unthinkable in the tightly managed onshore market," Robyn Mak, a Breakingviews columnist at Reuters, said. "Regulators are embracing animal spirits at a risky moment."

The company, formally known as Yushu Technology, priced its IPO at 150.80 yuan per share, valuing the Hangzhou-based firm at roughly 61 billion yuan ($9 billion). Retail investors bid for more than 53 million shares against 6.5 million allocated, prompting the company to expand the retail tranche to 9.7 million shares, or about 24 percent of the total offering. Unitree expects first-half 2026 net profit between 236 million and 283 million yuan.

The listing is the opening salvo in a pipeline of humanoid robotics IPOs in China, as the sector draws comparisons to the electric vehicle boom that produced dozens of public listings. Unitree plans to deploy proceeds toward embodied AI models, robotics research, and manufacturing expansion — investments that will determine whether humanoid robots can move from demonstration to mass deployment.

The IPO's reception reflects a broader shift in China's onshore capital markets, where regulators have shown increasing tolerance for high-valuation technology listings. Unitree's roughly 100-times earnings multiple would have been difficult to sustain in the tightly managed A-share market just a few years ago, when IPO pricing was subject to strict valuation caps.

The company's journey from a Hangzhou startup to the first publicly traded humanoid robot maker tracks the sector's rapid evolution. Founded in 2016 by Wang Xingxing, Unitree first gained recognition for its affordable quadruped robots — popularly known as robot dogs — before expanding into humanoid platforms. Its G1 humanoid robot has been showcased at conferences worldwide, including a demonstration at the ImagiNxt conference in Mumbai in May.

A 100-Times Earnings Benchmark

Unitree's debut is unlikely to be the last. Data from industry trackers shows AgiBot led humanoid robot shipments in the first half of 2026, and multiple Chinese robotics companies are reportedly preparing listings. The pipeline reflects investor appetite for exposure to embodied AI — the integration of artificial intelligence with physical machines — which has become one of the most closely watched technology themes in Chinese markets.

The comparison to the EV sector is instructive. When Chinese electric vehicle makers began listing in the late 2010s, the first wave of IPOs set valuation benchmarks that subsequent listings were measured against. A similar dynamic is now unfolding in robotics, with Unitree's 100-times earnings multiple likely to serve as a reference point for peers.

The Commercial Hurdle

The critical question is whether humanoid robots can deliver on their commercial promise. While the IPO's oversubscription demonstrates strong investor enthusiasm, the prospect of large-scale humanoid adoption remains uncertain because of existing challenges in task versatility and reliability. Unitree's own prospectus acknowledges these hurdles, with the company directing IPO proceeds toward research that addresses precisely these limitations.

For investors, the stakes are clear. If Unitree's valuation holds after listing, it could trigger a re-rating across the robotics sector and accelerate the IPO pipeline. If the stock stumbles, it could cool enthusiasm for subsequent listings. The first few weeks of trading will provide an early signal.

This article is for informational purposes only and does not constitute investment advice.